
TVARDI THERAPEUTICS INC
TVRD · NASDAQ
Updated at 2026-10-21 16:51:52
- Today's High
- $1.09
- Today’s Low
- $1.02
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.03
- Previous Close
- $0.99
- Volume
- 195.18K
- Market Cap
- $13.23M
- P/E Ratio
- --
- EPS
- $-2.77
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3 SUGAR CREEK CENTER BOULEVARD, SUGAR LAND, TX, UNITED STATES, 77478
- Country
- US
- Listing Date
- 2014-01-31
- Fiscal Year End
- December
- Shares Outstanding
- 12.49M
- CIK
- 0001346830
- Website
- tvarditherapeutics.com
Tvardi Therapeutics, Inc. is an innovative clinical-stage biopharmaceutical company focused on developing novel oncology therapies to meet critical unmet medical needs. Leveraging its proprietary drug discovery platform, Tvardi specializes in small molecule therapies designed to target protein degradation pathways, enhancing the effectiveness of cancer treatments. Its lead candidate, TVB-2640, is engineered to disrupt cancer cell survival mechanisms, reflecting the company's commitment to offering transformative therapeutic options. With a robust pipeline and a strong emphasis on scientific excellence, Tvardi is well-positioned to significantly influence the future of cancer treatment.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$6.62M
2026-03-31
$7.05M
2025-12-31
$7.58M
2025-09-30
$5.93M
Net Income
2026-06-30
-$6.45M
2026-03-31
-$6.8M
2025-12-31
-$7.27M
2025-09-30
-$5.52M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.69
2026-03-31
$-0.73
2025-12-31
$-0.78
2025-09-30
$-0.59
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$6.6M
2026-03-31
-$6.78M
2025-12-31
-$7.25M
2025-09-30
-$5.5M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $6.62M | $7.05M | $7.58M | $5.93M |
| Net Income | -$6.45M | -$6.8M | -$7.27M | -$5.52M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.69 | $-0.73 | $-0.78 | $-0.59 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$6.6M | -$6.78M | -$7.25M | -$5.5M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.